Federal Supply Schedule 36F79724D0073
Award Date
4/1/24
Last Date to Order
3/31/29
Federal Agency
Veterans Integrated Service Network 12
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 12 to MHC Medical Products, LLC. The contract is for invitro diagnostics, reagents, test kits, and test sets under FSS-65-VII. The contract has a potential value of $4,800,000.00 and a period of performance from August 1, 2018 to September 1, 2025. The contract was awarded as a multiple award, with no set-asides used. Pricing...
This Federal Supply Schedule (FSS) contract award to Avmedical LLC is for in-vitro diagnostics, reagents, test kits, and test sets under Schedule 65 VII. The $3,150,000 contract (36F79723D0041) was awarded on December 15, 2022 by the Department of Veterans Affairs and has a 5-year period of performance through December 14, 2027. The contract includes 535 awarded products across multiple Special Item Numbers (SINs) such as chemistry reagents, hematology reagents, microbiology supplies, phlebotomy...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to procure invitro diagnostics, reagents, test kits, and test sets. The contract was awarded on August 1, 2023 under GSA Schedule 65-VII for multiple vendors with a potential value of $300,000 and a period of performance through July 31, 2028. The contract aims to provide medical laboratories within the VA network with critical supplies for...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) to Medipurpose, Inc., provides in-vitro diagnostic reagents, test kits, and test sets. The $225,000 multiple-award contract has a performance period extending to March 14, 2025. Medipurpose, Inc., a self-certified small disadvantaged business and manufacturer of goods, was awarded this FSS contract under Schedule 65-VII, which covers in-vitro diagnostics, reagents, and test kits. The...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, provides 621 II, Medical Laboratory Testing & Analysis Services. The multiple-award contract has a ceiling value of $3,000,000.00 and a period of performance through October 31, 2029. The prime contractor, Southwest Regional PCR, L.L.C. (doing business as Microgen DX), is a self-certified small disadvantaged, veteran-owned business. The contract...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to American Molecular Laboratories Inc. under the Medical Laboratory Testing and Analysis Services (FSS-621-II) GSA Schedule. The contract aims to procure medical laboratory testing and analysis services for an estimated value of $225,000. The period of performance is from April 1, 2021 through March 31, 2026. Under this multiple award IDV,...
The federal contract IDV awarded to Medmira Laboratories Inc. is a Federal Supply Schedule (FSS) contract for in-vitro diagnostics, reagents, test kits, and test sets (FSS-65-VII). The $750,000.00 contract was awarded on Apr 15, 2025 by the Department of Veteran Affairs (VA) and has an ultimate completion date of Apr 14, 2030. As a multiple award FSS contract, Medmira Laboratories Inc. will provide the VA's Veterans Integrated Service Network 12 with a variety of in-vitro diagnostic products and...
The key products and services being delivered under this federal contract IDV award are in vitro diagnostic reagents, test kits, and related medical laboratory equipment and services. The prime contractor, Luminex Corporation, was awarded a Federal Supply Schedule (FSS) contract by the Department of Veterans Affairs (VA) to provide these specialized biological testing technologies and support services. Luminex's proprietary platforms, assays, and diagnostic solutions enable automated analysis of...
The Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Trividia Health, Inc. in November 2019 provides a mechanism for the VA to procure in-vitro diagnostics, reagents, test kits, and test sets. The multiple-award FSS contract, under GSA Schedule 65-VII, has a potential value of $29,469,263 and a period of performance through November 2025. This contract allows VA medical facilities nationwide, including the VA's Integrated Service Network (VISN) 12...
This federal supply schedule contract provides invitro diagnostics, reagents, test kits, and test sets under special item number 555-6. Key products include oligonucleotides, probes, and custom DNA/RNA synthesized at different scales. The contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Integrated DNA Technologies, Inc. with a potential value of $2.5 million. The base period of performance is from June 1, 2017...